Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Trulieve Cannabis (TCNNF) Depreciation & Amortization - Total (2020 - 2023)

Trulieve Cannabis has reported Depreciation & Amortization - Total over the past 4 years, most recently at -$36.0 million for Q4 2023.

  • For Q4 2023, Depreciation & Amortization - Total fell 41.89% year-over-year to -$36.0 million; the TTM value through Sep 2024 reached -$36.0 million, down 360.87%, while the annual FY2025 figure was $53.1 million, 137.99% up from the prior year.
  • Depreciation & Amortization - Total for Q4 2023 was -$36.0 million at Trulieve Cannabis, down from $18.7 million in the prior quarter.
  • Over five years, Depreciation & Amortization - Total peaked at $20.5 million in Q1 2023 and troughed at -$36.0 million in Q4 2023.
  • A 4-year average of $4.9 million and a median of $7.3 million in 2021 define the central range for Depreciation & Amortization - Total.
  • On a YoY basis, Depreciation & Amortization - Total climbed as much as 176.79% in 2022 and fell as far as 2258.74% in 2022.
  • Year by year, Depreciation & Amortization - Total stood at $10.4 million in 2020, then tumbled by 110.35% to -$1.1 million in 2021, then plummeted by 2258.74% to -$25.4 million in 2022, then plummeted by 41.89% to -$36.0 million in 2023.
  • Business Quant data shows Depreciation & Amortization - Total for TCNNF at -$36.0 million in Q4 2023, $18.7 million in Q3 2023, and $20.5 million in Q1 2023.